Open access
Open access
Powered by Google Translator Translator

Infectious Diseases (all articles)

What are the Sinopharm and Sinovac vaccines? And how effective are they? Two experts explain.

5 Jul, 2021 | 02:28h | UTC

Related: What are the Sinopharm and Sinovac vaccines? And how effective are they? Two experts explain – The Conversation

 

Germany issues world’s strongest recommendation for mixing Covid-19 vaccines.

5 Jul, 2021 | 02:27h | UTC

Germany issues world’s strongest recommendation for mixing Covid-19 vaccines – CNN

Related: [Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other. All combinations worked well, priming the immune system”.

 

[Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other. All combinations worked well, priming the immune system”.

2 Jul, 2021 | 11:47h | UTC

Mixing Covid jabs has good immune response, study finds – BBC

Original study (preprint): Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine – SSRN Preprints with the Lancet

 

The 3 Simple Rules That Underscore the Danger of Delta – “Vaccines are still beating the variants, but the unvaccinated world is being pummeled”.

2 Jul, 2021 | 11:45h | UTC

The 3 Simple Rules That Underscore the Danger of Delta – The Atlantic

 

Patient page: return to play after COVID-19 infection in children

2 Jul, 2021 | 11:21h | UTC

Return to Play After COVID-19 Infection in Children – JAMA Pediatrics

 

Vaccine-induced immune thrombotic thrombocytopenia (VITT) – a novel clinico-pathological entity with heterogeneous clinical presentations.

2 Jul, 2021 | 11:39h | UTC

Vaccine-induced immune thrombotic thrombocytopenia (VITT) – a novel clinico-pathological entity with heterogeneous clinical presentations – British Journal of Haematology

Commentary: Blood clots related to AstraZeneca/Oxford vaccine can be mitigated with early detection – MedicalXpress

 

Viewpoint | Sharing technology and vaccine doses to address global vaccine inequity and end the COVID-19 pandemic.

2 Jul, 2021 | 11:22h | UTC

Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic – JAMA

 

Delirium in COVID-19: can we make the unknowns knowns?

2 Jul, 2021 | 11:17h | UTC

Delirium in COVID-19: can we make the unknowns knowns? – Intensive Care Medicine

 

Commentary on Twitter

 

[Press release] J&J single-shot COVID-19 vaccine generates strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.

2 Jul, 2021 | 11:38h | UTC

Press release: Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response

Commentary: J&J Covid Shot Neutralizes Delta Variant, Company Says – Bloomberg (a few articles per month are free)

 

COVID-19 vaccines reduce severity, length, viral load for those who still get infected.

1 Jul, 2021 | 09:57h | UTC

COVID-19 vaccine reduces severity, length, viral load for those who still get infected – University of Arizona Health Sciences

Original study: Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines – New England Journal of Medicine

 

Commentary on Twitter

 

RCT: Novavax vaccine conferred 89.7% protection against symptomatic SARS-CoV-2 infection and 100% protection against hospitalizations or deaths.

1 Jul, 2021 | 09:59h | UTC

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine – New England Journal of Medicine

Audio interview: Audio Interview: Another New Covid-19 Vaccine – New England Journal of Medicine

Related: Opinion | The mRNA vaccines are extraordinary, but Novavax is even better

 

Analysis: How long does covid-19 immunity last?

1 Jul, 2021 | 09:56h | UTC

How long does covid-19 immunity last? – The BMJ

 

The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection.

1 Jul, 2021 | 09:55h | UTC

The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection – Current Neurology and Neuroscience Reports

 

Systematic review: Border controls, restricted entry, quarantine essential for curbing COVID-19 and future pandemics.

1 Jul, 2021 | 09:53h | UTC

News release: Border controls, restricted entry, quarantine essential for curbing COVID-19 and future pandemics – British Medical Journal

Original study: Lessons from countries implementing find, test, trace, isolation and support policies in the rapid response of the COVID-19 pandemic: a systematic review – BMJ Open

Commentary: Strategies ID’d Than Can Interrupt Spread of Infectious Disease – HealthDay

 

Perspective | Why no one is sure if Delta is deadlier – “The variants are spreading faster, but they don’t necessarily have incentive to kill more often”.

1 Jul, 2021 | 09:52h | UTC

Why No One Is Sure If Delta Is Deadlier – The Atlantic

 

Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms.

30 Jun, 2021 | 10:24h | UTC

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms – Frontiers in Microbiology

 

Case Series: Myocarditis following immunization with mRNA COVID-19 vaccines.

30 Jun, 2021 | 10:22h | UTC

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military – JAMA Cardiology

See also: Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination – JAMA Cardiology

Editorials: Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines AND Temporal Associations Between Immunization With the COVID-19 mRNA Vaccines and Myocarditis: The Vaccine Safety Surveillance System Is Working

Commentary: More Evidence Links Myocarditis to mRNA COVID-19 Vaccines – TCTMD

Related: CDC: mRNA vaccines are likely linked to cases of myocarditis and pericarditis – 1,226 cases of myocarditis or pericarditis have been reported mostly in people under 30.

 

Commentary on Twitter

 

Exclusive-WHO estimates COVID-19 boosters needed yearly for most vulnerable.

30 Jun, 2021 | 10:17h | UTC

Exclusive-WHO estimates COVID-19 boosters needed yearly for most vulnerable – Reuters

Related: CDC group says there isn’t enough data yet to recommend Covid booster shots – CNBC

 

Covid: Masks upgrade cuts infection risk, research finds.

30 Jun, 2021 | 10:16h | UTC

Covid: Masks upgrade cuts infection risk, research finds – BBC

 

COVID-19 cut Brazilian life span almost 2 years in 2021.

30 Jun, 2021 | 10:19h | UTC

COVID-19 cut Brazilian life span almost 2 years in 2021 – CIDRAP

Original Study: Reduction in life expectancy in Brazil after COVID-19 – Nature Medicine

 

Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.

30 Jun, 2021 | 10:13h | UTC

Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome – European Heart Journal

 

Consensus Statement: The role of lung ultrasound in COVID-19 disease.

30 Jun, 2021 | 10:12h | UTC

The role of lung ultrasound in COVID-19 disease – Insights into Imaging

 

Should I get my second AstraZeneca dose? Yes, it almost doubles your protection against Delta.

30 Jun, 2021 | 10:11h | UTC

Should I get my second AstraZeneca dose? Yes, it almost doubles your protection against Delta – The Conversation

Related: Effectiveness of COVID-19 vaccines against the B.1.617.2 variant – medRxiv

 

IHME COVID-19 model has been updated for over 200 world locations.

29 Jun, 2021 | 10:13h | UTC

COVID-19 Projections – Institute for Health Metrics and Evaluation

Video: Insights from IHME’s latest COVID-19 model update

 

Commentary on Twitter

 

Phase 1/2 RCT: CoronaVac is well tolerated and safe and induces strong humoral responses in children and adolescents aged 3–17 years.

29 Jun, 2021 | 10:09h | UTC

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial – The Lancet Infectious Diseases

Invited commentary: COVID-19 vaccines for children younger than 12 years: are we ready? – The Lancet Infectious Diseases

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.